Vol 72, No 3 (2021)
Clinical vignette
Published online: 2021-06-30

open access

Page views 1055
Article views/downloads 877
Get Citation

Connect on Social Media

Connect on Social Media

Increased efficacy of hypothyroidism control with liquid levothyroxine [Większa skuteczność lewotyroksyny w postaci płynnej w wyrównywaniu niedoczynności tarczycy]

Marek Ruchała1
Pubmed: 34292578
Endokrynol Pol 2021;72(3):271-275.

Abstract

Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file

References

  1. Okosieme OE, Belludi G, Spittle K, et al. Adequacy of thyroid hormone replacement in a general population. QJM. 2011; 104(5): 395–401.
  2. Ruchała M, Szczepanek-Parulska E, Zybek A. The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. Endokrynol Pol. 2012; 63(4): 318–323.
  3. Yue CS, Scarsi C, Ducharme MP. Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung. 2012; 62(12): 631–636.
  4. Fallahi P, Ferrari SM, Antonelli A. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study. Endocrine. 2016; 52(3): 597–601.
  5. Gietka-Czernel M, Hubalewska-Dydejczyk A, Kos-Kudła B, et al. Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation - Tirosint SOL [Opinia ekspertów dotycząca stosowania płynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynność tarczycy]. Endokrynol Pol. 2020; 71(5): 441–465.